Compare YOU & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YOU | AMRX |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 3.7B |
| IPO Year | 2021 | 2018 |
| Metric | YOU | AMRX |
|---|---|---|
| Price | $56.17 | $13.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $50.29 | $15.60 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $900,779,000.00 | N/A |
| Revenue This Year | $17.56 | $4.48 |
| Revenue Next Year | $14.73 | $7.13 |
| P/E Ratio | ★ $20.59 | $63.20 |
| Revenue Growth | ★ 16.91 | N/A |
| 52 Week Low | $23.76 | $7.02 |
| 52 Week High | $56.51 | $15.42 |
| Indicator | YOU | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.83 | 54.88 |
| Support Level | $45.31 | $12.50 |
| Resistance Level | N/A | $13.54 |
| Average True Range (ATR) | 2.68 | 0.41 |
| MACD | 0.16 | 0.16 |
| Stochastic Oscillator | 96.05 | 62.57 |
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in creating a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports, helping to make the travel experience safe and easy. The Company's operations are mainly focused on growing and maintaining its secure identity network across multiple offerings in both aviation and non-aviation channels.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.